Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jul-Aug;68(4):318-26.
doi: 10.4212/cjhp.v68i4.1472.

Addressing Concerns about Changing the Route of Antimicrobial Administration from Intravenous to Oral in Adult Inpatients

Affiliations
Review

Addressing Concerns about Changing the Route of Antimicrobial Administration from Intravenous to Oral in Adult Inpatients

Lizanne Béïque et al. Can J Hosp Pharm. 2015 Jul-Aug.

Abstract

Background: Many health care institutions are in the process of establishing antimicrobial stewardship programs. Changing the route of administration of antimicrobial agents from intravenous to oral (IV to PO) is a simple, well-recognized intervention that is often part of an antimicrobial stewardship program. However, the attending health care team may have concerns about making this switch.

Objectives: To provide insights into common concerns related to IV to PO conversion, with the aim of helping antimicrobial stewardship teams to address them.

Data sources: Published clinical trials and reviews were identified from a literature search of Ovid MEDLINE with the keywords (step down or switch or conversion or transition or sequential) and (antibiotics or antibacterial agents or antimicrobial or anti-infective agents).

Data synthesis: The following issues are addressed in this review: benefits of the oral route, serum concentrations yielded by the oral formulation, source of pharmacokinetic data, clinical outcomes, provision of care in the intensive care unit, fear of therapeutic failure, and administration of antimicrobials via feeding tube.

Conclusions: When considering a change to oral therapy, it is important to have a thorough understanding of key aspects of the antimicrobial agent, the patient, and the disease being treated. The antimicrobial stewardship team has an important role in facilitating IV to PO conversion, educating prescribers, and addressing any concerns or reservations that may interfere with timely transition from IV to PO administration.

Contexte: Bon nombre d’établissements de santé sont en voie de mettre en place de programmes de gestion responsable des antimicrobiens. Changer de voie d’administration des agents antimicrobiens en passant d’une administration intraveineuse à une administration orale est une intervention simple et reconnue qui fait souvent partie de ces programmes. Cependant, opérer un tel changement pourrait soulever des préoccupations chez les membres de l’équipe de soins de santé traitante.

Objectifs: Dégager une meilleure compréhension des préoccupations courantes entourant le passage de la voie d’administration intraveineuse à la voie d’administration orale dans le but d’aider les équipes de gestion responsable des antimicrobiens à y répondre.

Sources des données: Des analyses documentaires ainsi que des essais cliniques publiés ont été recensés grâce à une recherche dans Ovid MEDLINE à l’aide des mots clés (step down [passage] ou switch [échange] ou conversion [conversion] ou transition [transition] ou sequential [successif]) et (antibiotics [antibiotiques]) ou antibacterial agents [agents antibactériens] ou antimicrobial [antimicrobien] ou anti-infective agents [agents anti-infectieux]).

Synthèse des données: Les préoccupations suivantes sont abordées dans la présente analyse : les avantages de la voie orale, les concentrations sériques obtenues grâce aux préparations orales, la source des données pharmacocinétiques, les résultats cliniques, la prestation des soins à l’unité des soins intensifs, la peur de l’échec thérapeutique et l’administration des antimicrobiens par sonde gastrique.

Conclusions: Lorsque l’on envisage de passer à un traitement par voie orale, il est important de posséder une connaissance approfondie des principaux aspects de l’agent antimicrobien, de l’état du patient et de la maladie traitée. L’équipe de gestion responsable des antimicrobiens détient un rôle important pour ce qui est de simplifier le passage d’une administration intraveineuse à une administration orale, d’éduquer les prescripteurs et de répondre aux préoccupations et doutes qui pourraient faire obstacle à un tel passage en temps voulu.

Keywords: IV to PO transition; antimicrobial stewardship programs; antimicrobials; intravenous therapy; oral therapy; step-down.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Goff DA, Bauer KA, Reed EE, Stevenson KB, Taylor JJ, West JE. Is the “low-hanging fruit” worth picking for antimicrobial stewardship programs? Clin Infect Dis. 2012;55(4):587–92. doi: 10.1093/cid/cis494. - DOI - PubMed
    1. Lau BD, Pinto BL, Thiemann DR, Lehmann CU. Budget impact analysis of conversion from intravenous to oral medication when clinically eligible for oral intake. Clin Ther. 2011;33(11):1792–6. doi: 10.1016/j.clinthera.2011.09.030. - DOI - PubMed
    1. Kuper K. Intravenous to oral therapy conversion. In: Murdaugh LB, editor. Competence assessment tools for health-system pharmacies. 4th ed. Bethesda (MD): American Society of Health-System Pharmacists; 2008. pp. 347–60.
    1. Lelekis M, Gould IM. Sequential antibiotic therapy for cost containment in the hospital setting: why not? J Hosp Infect. 2001;48(4):249–57. doi: 10.1053/jhin.2001.1006. - DOI - PubMed
    1. Burgess D. Antimicrobial regimen selection. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy a pathophysiological approach. 8th ed. Toronto (ON): The McGraw-Hills Companies; 2011. pp. 1813–23.

LinkOut - more resources